CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy in NSCLC, HNSCC and Other Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04892849
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:18.168852+00:00
Published At: 2025-09-17T00:00:00+00:00
Record Updated At: 2025-09-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["HNSCC", "NSCLC", "Esophageal Cancer", "Urothelial Carcinoma", "Renal Cell Carcinoma", "Squamous Cell Carcinoma of the Skin", "Small Cell Bronchial Carcinomas"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-17"
protocolSection.identificationModule.nctId: "NCT04892849"
protocolSection.identificationModule.officialTitle: "Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy in NSCLC, HNSCC and Other Solid Tumors"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.